|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.36 EUR | -3.34% |
|
-28.09% | -29.10% |
| 01-23 | CARL ZEISS MEDITEC AG : Berenberg sticks Neutral | ZD |
| 01-23 | CARL ZEISS MEDITEC AG : Deutsche Bank remains Neutral | ZD |
Evolution of the Average Target: Carl Zeiss Meditec AG
Evolution of the Target Price: Carl Zeiss Meditec AG
Changes in Analyst Recommendations: Carl Zeiss Meditec AG
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +47.07% | |||||
| +4.25% | |||||
| +16.08% | |||||
| +11.93% | |||||
| +34.48% | |||||
| +29.93% | |||||
| +15.96% | |||||
| +25.63% | |||||
| +15.33% | |||||
| +15.83% | |||||
| Average | +21.65% | |||||
| Weighted average by Cap. | +16.35% |
Analysts' Consensus
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| alphavalue | Anas Patel |
| BERENBERG | Sam England |
| BARCLAYS | Jonathon Unwin |
| JPMORGAN | David Adlington |
| RBC | Jack Reynolds-Clark |
| UBS | Graham Doyle |
| GOLDMAN SACHS | Richard Felton |
| BERNSTEIN RESEARCH | Susannah Ludwig |
| RBC Capital Markets | |
| DZ BANK | Sven Kürten |
| DEUTSCHE BANK RESEARCH | Falko Friedrichs |
| HAUCK AUFHÄUSER INVESTMENT BANKING | Alexander Galitsa |
| HSBC | |
| Equita SIM | |
| BANK OF AMERICA (BOFA) | Julien Ouaddour |
| HAUCK AUFHÄUSER LAMPE | Alexander Galitsa |
| DEUTSCHE BANK | Falko Friedrichs |
| KEPLER CHEUVREUX | Oliver Reinberg |
| NORDLB | Holger Fechner |
| HAUCK & AUFHÄUSER | Aliaksandr Halitsa |
| INDEPENDENT RESEARCH | Tobias Gottschalt |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- AFX Stock
- Consensus Carl Zeiss Meditec AG
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition